In a significant step towards enhancing cancer care across the nation, the newly established National Cancer Board convened for its inaugural meeting today. This board is set to play a crucial role in overseeing the government’s ambitious National Cancer Plan, which lays out over 100 commitments aimed at advancing diagnosis, treatment, and overall quality of life for cancer patients.
The board will focus on identifying areas that require urgent attention and advising government ministers on actions needed to ensure that all patients receive optimal care. Notably, it will feature expert leads dedicated to addressing the needs of rare cancers, as well as focusing on children, young people, and the inequalities present within cancer care.
Strengthening Leadership in Cancer Care
Health and Social Care Secretary Yvette Cooper highlighted the personal impact of cancer on families, underscoring the importance of the National Cancer Plan in delivering earlier diagnoses and more effective treatments. She expressed enthusiasm about the board’s role in evaluating progress and ensuring that patient voices are central to its work.
Cooper stated, “I look forward to working with Anita Charlesworth and her team to deliver the change that every person in our country wants to see, and from which millions of our loved ones will benefit in the years to come.”
Leading the board alongside Mark Cubbon from NHS England, Anita Charlesworth will ensure that the board’s operations are transparent and accountable. She will be supported by experts such as Dr Rob Metcalf, who will focus on rare cancers, Dr Dianne Addei, who will address inequalities, and Ashley Ball-Gamble, who will represent children and young people with cancer.
Regular Assessments and Long-term Goals
The board will meet quarterly and will publish an annual assessment to track progress. After a three-year period, a detailed review will be conducted to evaluate the effectiveness of the National Cancer Plan and to determine areas needing enhancement.
Anita Charlesworth remarked, “Half of us will be diagnosed with cancer during our lives, so this matters profoundly to patients and families right across the country. The National Cancer Plan is rightly ambitious, and this Board will maintain a relentless focus on earlier diagnosis and making sure innovation reaches every patient, no matter who they are or where they live.”
Professor Peter Johnson, the national clinical director for cancer at NHS England, also emphasised the plan’s commitment to delivering world-class care for cancer patients. He noted that the collaboration of clinical experts, charity leaders, and patients is essential for scrutinising progress and meeting the plan’s objectives.
Aiming for a Healthier Future
The National Cancer Plan, which was published in February 2026, aims for three in four individuals diagnosed with cancer to either be cancer-free or in good health five years post-diagnosis by the year 2035. In addition to improving care performance, the government is advancing key elements of the plan, including enhanced access to lung cancer screening and the establishment of Community Diagnostic Centres.
Michelle Mitchell, Chief Executive of Cancer Research UK, acknowledged the need for strong leadership and accountability to achieve lasting change for those affected by cancer. She expressed optimism about the board’s efforts to address critical areas such as early detection and reducing waiting times for treatment.
Commitment to Addressing Inequalities
Gemma Peters, Chief Executive of Macmillan Cancer Support, highlighted the significance of the board’s first meeting as a pivotal moment in turning the National Cancer Plan into actionable outcomes. She noted that the appointment of a dedicated lead for inequalities is a vital step in ensuring that the plan’s commitments are realised.
Chris Walden, CEO of Cancer52, reiterated the importance of the board in incorporating the perspectives of charities and patients, particularly those with rare and less common cancers. He expressed pride in contributing to a plan that prioritises the needs of these often-overlooked groups.
Rachel Kirby-Rider, Chief Executive of Young Lives vs Cancer, remarked on the historic inclusion of a chapter dedicated to children and young people within the National Cancer Plan. She welcomed the appointment of Ashley Ball-Gamble as the lead for this demographic, recognising his commitment to improving the experiences of young cancer patients.
Collaborative Efforts for Progress
Dr Sara Stoneham, Chair of the Children & Young People’s Cancer Association, expressed satisfaction with the board’s focus on implementing recommendations specifically for children and young people. She emphasised the importance of collaboration between government, NHS, charities, and the wider cancer community to ensure that the ambitions of the National Cancer Plan are effectively realised.
The establishment of the National Cancer Board marks a pivotal moment in the ongoing efforts to transform cancer care in the UK, with a clear commitment to addressing the diverse needs of all patients.